Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 3 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 467 Neoplasms 315 Carcinoma, Non-Small-Cell Lung 269 Prostatic Neoplasms 215 Colorectal Neoplasms 207 Lung Neoplasms 176 Multiple Myeloma 123 Melanoma 110 Carcinoma, Renal Cell 107 Ovarian Neoplasms 94 Carcinoma, Hepatocellular 78 Pancreatic Neoplasms 69 Urinary Bladder Neoplasms 65 Stomach Neoplasms 64 Neoplasm Metastasis 64 Leukemia, Lymphocytic, Chronic, B-Cell 62 Colonic Neoplasms 59 Leukemia, Myeloid, Acute 53 Uterine Cervical Neoplasms 50 Recurrence 49 Liver Neoplasms 46 Lymphoma, Follicular 45 Lymphoma 45 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39 Esophageal Neoplasms 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Lymphoma, Large B-Cell, Diffuse 35 Hematologic Neoplasms 35 Head and Neck Neoplasms 35 Lymphoma, Non-Hodgkin 34

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × Advanced Ovarian Cancer × Clear all

NCT05775549 2024-09-20

FLAME

AstraZeneca

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡